Shots:

• Roche reported the CE mark availability of its v-TAC digital diagnostic solution- allowing clinicians to get results for arterial blood gas values from patients with respiratory or metabolic abnormalities. The tool helps in simplifying the screening- diagnosis and monitoring of patients with respiratory compromise in the COVID-19 pandemic
• Roche’s v-TAC requires no specially trained staff to draw an arterial blood sample and enables them to withdraw a venous blood sample instead and digitally convert values into arterial blood gas values- which help HCPs to perform other tasks
• Roche’s v-TAC is fully integrated for use with cobas b 123 POC and cobas b 221 systems using the Roche cobas infinity POC solution. The company acquired the v-TAC technology with the acquisition of Obi Medical Aps in Mar’2020

Click here ­to­ read full press release/ article 

Ref: Roche | Image: Roche